PhD
Saint Louis University
Stanley Andrisse, PhD, MBA
Physiology and Biophysics
Dr. Stanley Andrisse is a tenure track faculty in the Department of Physiology at Howard University College of Medicine, where he brings expertise in endocrinology, physiology, and metabolic health. His research primarily explores insulin resistance, liver-specific signaling pathways, and metabolic disease. Dr. Andrisse is also the Executive Director of the nonprofit From Prison Cells to PhD, an organization he founded to support justice-impacted individuals pursuing higher education and careers in STEM.
A recognized advocate for educational access and criminal justice reform, Dr. Andrisse has received numerous awards and speaks widely on topics such as systemic health disparities and science policy. His work has been supported by the NIH, NSF, and other institutions committed to expanding educational opportunities for underrepresented groups. Dr. Andrisse completed his Ph.D. in Physiology at Saint Louis University and his postdoctoral training at Johns Hopkins Medicine.
Saint Louis University
Lindenwood University
Lindenwood University
FUNDED GRANTS AND CONTRACTS
Title: The cellular molecular regulation of differing mechanisms of insulin resistance.
Grant #: NIH 1R01DK126892
Years: July 2022 to June 2027 (5-year grant)
Project Summary: Insulin resistance is when cells in your muscles, fat, and liver don’t respond well to insulin
and can’t easily take up glucose from your blood, a condition known as prediabetes, affecting more than 84
million people ages 18 and older in the United States, about 1 out of every 3 adults. Researchers don’t fully
understand what causes insulin resistance and prediabetes, but they think that excess weight and lack of
physical activity are major factors. Here, we study three models of insulin resistance in an animal model to
better understand the mechanisms involved in insulin resistance related to excess fat intake, excess sugar
intake, and excess androgens.
Title: Bridges to the Baccalaureate Research Training Program at Howard University and Baltimore City
Community College
Grant #: NIH 1T34GM142610
Years: Aug 2022 to July 2027 (5-year grant)
Project Summary: Bridges to Baccalaureate students would be recruited and provided educational readiness
by Prison to Professionals while still incarcerated, transition to a 2-year associates granting school (Baltimore
City Community College, BCCC), be provided skills and methods development during their 2-years at BCCC,
participate in a 10-week STEM research internship at Howard (HU) University, then transition to a 4-year
Bachelors granting school, HU. Thus, this project is taking the highly innovative approach to intersect the
worlds of research, education, and incarceration by creating a ground-breaking prison-to-college-and-STEM
pipeline.
Title: Analysis of hepatic Androgen Receptor (AR) knockdown for targeted treatment of Polycystic Ovary
Syndrome (PCOS).
Contract #: GB-45025_Alnylam Pharmaceuticals
Years: Feb 2023 to Feb 2024 (1-year)
Project Summary: Genetic deletion of hepatic AR has been shown to be very effective in ameliorating the
metabolic impact of PCOS in a mouse model using low-dose DHT (Andrisse 2021). The current study will use
proprietary therapeutic compounds to prevent the development of insulin resistance in female mice.